SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-016009
Filing Date
2021-11-15
Accepted
2021-11-15 16:33:18
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20210930x10q.htm   iXBRL 10-Q 1849244
2 EX-31.1 osmt-20210930xex31d1.htm EX-31.1 10537
3 EX-31.2 osmt-20210930xex31d2.htm EX-31.2 10450
4 EX-32.1 osmt-20210930xex32d1.htm EX-32.1 7171
5 EX-32.2 osmt-20210930xex32d2.htm EX-32.2 8259
  Complete submission text file 0001558370-21-016009.txt   7763707

Data Files

Seq Description Document Type Size
6 EX-101.SCH osmt-20210930.xsd EX-101.SCH 47969
7 EX-101.CAL osmt-20210930_cal.xml EX-101.CAL 85792
8 EX-101.DEF osmt-20210930_def.xml EX-101.DEF 247147
9 EX-101.LAB osmt-20210930_lab.xml EX-101.LAB 453846
10 EX-101.PRE osmt-20210930_pre.xml EX-101.PRE 394846
11 EXTRACTED XBRL INSTANCE DOCUMENT osmt-20210930x10q_htm.xml XML 1354227
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 211411429
SIC: 2834 Pharmaceutical Preparations